Drunk When You re Not A 67 year old male presents with feeling off balance

Similar documents
DIFFERENTIAL DIAGNOSIS SARAH MARRINAN

Evaluation of Parkinson s Patients and Primary Care Providers

III./3.1. Movement disorders with akinetic rigid symptoms

Pietro Cortelli. IRCCS Istituto delle Scienze Neurologiche di Bologna DIBINEM, Alma Mater Studiorum - Università di Bologna

MULTI SYSTEM ATROPHY: REPORT OF TWO CASES Dipu Bhuyan 1, Rohit Kr. Chandak 2, Pankaj Kr. Patel 3, Sushant Agarwal 4, Debjanee Phukan 5

Niall Quinn. Professor of Clinical Neurology UCL IoN & NHNN Queen Square London UK

Multiple System Atrophy

A guide to Multiple System Atrophy for: General Practitioners

Atypical parkinsonism

Evolution of a concept: Apraxia/higher level gait disorder. ataxia v. apraxia gait = limb apraxia. low, middle, high gait disturbance levels

Overview. Overview. Parkinson s disease. Secondary Parkinsonism. Parkinsonism: Motor symptoms associated with impairment in basal ganglia circuits

Sleep-Disordered Breathing and Risk of Sudden Death in Multiple System Atrophy

Early Clinical Features of Parkinson s Disease and Related Disorders. Dr. Alastair Noyce

Parkinson s Disease in the Elderly A Physicians perspective. Dr John Coyle

Joint Session with ACOFP and Mayo Clinic. Parkinson's Disease: 5 Pearls. Jay Van Gerpen, MD

Parkinson Disease. Lorraine Kalia, MD, PhD, FRCPC. Presented by: Ontario s Geriatric Steering Committee

:{ic0fp'16. Geriatric Medicine: Blood Pressure Monitoring in the Elderly. Terrie Ginsberg, DO, FACOI

Parkinson s Disease. Prevalence. Mark S. Baron, M.D. Cardinal Features. Clinical Characteristics. Not Just a Movement Disorder

International Journal of Health Sciences and Research ISSN:

Movement Disorders. Psychology 372 Physiological Psychology. Background. Myasthenia Gravis. Many Types

Non-Motor Symptoms of Parkinson s Disease

Differential Diagnosis of Hypokinetic Movement Disorders

Parkinson s Disease Initial Clinical and Diagnostic Evaluation. J. Timothy Greenamyre, MD, PhD

The PSP Association. Presentation on the symptoms, care and support of patients with PSP.

Parkinson s Disease Update. Presented by Joanna O Leary, MD Movement disorder neurologist Providence St. Vincent s

Subthalamic Nucleus Deep Brain Stimulation (STN-DBS)

Parkinson s Disease: initial diagnosis, initial treatment & non-motor features. J. Timothy Greenamyre, MD, PhD

The Parkinson s You Can t See

Parts of the motor circuits

Multiple choice questions: ANSWERS

Identification number: TÁMOP /1/A

PARKINSON S PRIMER. Dr. Kathryn Giles MD, MSc, FRCPC Cambridge, Ontario, Canada

Objectives. Distinguishing Parkinson s disease from other parkinsonian and tremor syndromes. Characteristics. Basal Ganglia Structures

Functional Distinctions

What if it s not Alzheimer s? Update on Lewy body dementia and frontotemporal dementia

PARKINSON S DISEASE. Nigrostriatal Dopaminergic Neurons 5/11/16 CARDINAL FEATURES OF PARKINSON S DISEASE. Parkinson s disease

Non-motor symptoms as a marker of. Michael Samuel

Multiple System Atrophy Manifested by Bilateral Vocal Cord Palsy as an Initial Sign

Parkinson s Disease Associated Sleep Disturbance Ehsan M. Hadi, MD, MPH. Dignity Health Neurological Institute

Movement Disorders: A Brief Overview

Comprehensive Approach to DLB Management

Enhanced Primary Care Pathway: Parkinson s Disease

PARKINS ON CENTER. Parkinson s Disease: Diagnosis and Management. Learning Objectives: Recognition of PD OHSU. Disclosure Information

Parkinson s Disease. Sirilak yimcharoen

Extrapyramidal Motor System. Basal Ganglia or Striatum. Basal Ganglia or Striatum 3/3/2010

Corporate Medical Policy

The PD You Don t See: Cognitive and Non-motor Symptoms

Clinical Characteristics of Patients with Multiple System Atrophy in Singapore

Dizziness, postural hypotension and postural blackouts: Two cases suggesting multiple system atrophy

10th Medicine Review Course st July Prakash Kumar

CN V! touch! pain! Touch! P/T!

Neurodegenerative Disease. April 12, Cunningham. Department of Neurosciences

ASHI691: Why We Fall Apart: The Neuroscience and Neurophysiology of Aging. Dr. Olav E. Krigolson Lecture 5: PARKINSONS DISEASE

Središnja medicinska knjižnica

Faculty. Joseph Friedman, MD

Multiple-system atrophy is an adult-onset, fatal neurodegenerative

DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017.

Program Highlights. Michael Pourfar, MD Co-Director, Center for Neuromodulation New York University Langone Medical Center New York, New York

VL VA BASAL GANGLIA. FUNCTIONAl COMPONENTS. Function Component Deficits Start/initiation Basal Ganglia Spontan movements

The PD You Don t See: Cognitive and Non-motor Symptoms

Dementia Update. Daniel Drubach, M.D. Division of Behavioral Neurology Department of Neurology Mayo Clinic Rochester, Minnesota

Date of Referral: Enhanced Primary Care Pathway: Parkinson s Disease

The NIHSS score is 4 (considering 2 pts for the ataxia involving upper and lower limbs.

Vague Neurological Disorders

Optimizing Clinical Communication in Parkinson s Disease:

CONTROL OF MOVEMENT BY THE BRAIN A. PRIMARY MOTOR CORTEX:

Parkinson s Disease Current Treatment Options

A. PRIMARY MOTOR CORTEX: - responsible for - like somatosensory cortex, primary motor cortex show (motor homunculus) - amount of cortex devoted to

High Yield Neurological Examination

Brain and Central Nervous System Cancers

Biology 3201 Nervous System # 7: Nervous System Disorders

FOUNDATION OF UNDERSTANDING PARKINSON S DISEASE

Dizziness: Neurological Aspect

Parkinsons Disease & Movement Disorder Aug 11-13, Frankfurt l Dr. Geeta Shroff

Multiple system atrophy (MSA) is a sporadic adult-onset

Acute Vestibular Syndrome (VS or Stroke?) Three-step H.I.N.T.S. eye examination

MAXIMIZING FUNCTION IN PARKINSON S DISEASE

MOVEMENT DISORDERS AND DEMENTIA

Pathogenesis of Degenerative Diseases and Dementias. D r. Ali Eltayb ( U. of Omdurman. I ). M. Path (U. of Alexandria)

WELCOME. Parkinson s 101 for the Newly Diagnosed. Today s Topic: Parkinson s Basics presented by Cari Friedman, LCSW

Parkinson s Disease and other related movement disorders a video guide to diagnosis

ORIGINAL CONTRIBUTION. Brain Magnetic Resonance Imaging in Multiple-System Atrophy and Parkinson Disease

14 - Central Nervous System. The Brain Taft College Human Physiology

A Hypothesis Driven Approach to the Neurological Exam

Parkinson s Disease WHERE HAVE WE BEEN, WHERE ARE WE HEADING? CHARLECE HUGHES D.O.

M. Carranza M. R. Snyder J. Davenport Shaw T. A. Zesiewicz. Parkinson s Disease. A Guide to Medical Treatment

Scott J Sherman MD, PhD The University of Arizona PARKINSON DISEASE

Treatment of Parkinson s Disease: Present and Future

Types of involuntary movements

Common Forms of Dementia Handout Package

8/28/2017. Behind the Scenes of Parkinson s Disease

Depression & Anxiety. What can I do? What are other possible treatments? What is this? Why does this happen? KEY POINTS

Movement Disorders- Parkinson s Disease. Fahed Saada, MD March 8 th, th Family Medicine Refresher Course St.

Update on functional brain imaging in Movement Disorders

Basal ganglia Sujata Sofat, class of 2009

Dysarthria and Dysphagia: a Neurology Perspective William Meador, MD Assistant Professor of Neurology, UAB

Neurological Examination

Revised criteria for the clinical diagnosis of dementia with Lewy. Dementia with Lewy bodies. (Dementia with Lewy Bodies)

Transcription:

Drunk When You re Not A 67 year old male presents with feeling off balance Kiera McElrone, DO Internal Medicine/Pediatrics Residency Maine Medical Center September 2017 ACP Bar Harbor Meeting

Chief Complaint NOVEMBER 2015 Telephone call to primary care office. 67 year old has been feeling off balance for awhile but starting to feels worse. When he walks, he feels like he is drunk.

History of Present Illness NOVEMBER 2015 Balance and coordination issues since 2013 after right hip surgery Plays tennis and cannot swing well Multiple falls Occasional slurred speech Developed nighttime urinary incontinence (normal prostate exam in May 2015)

Past Medical History Past Medical History Rheumatoid Arthritis REM Sleep Disorder- since around 2011 Erectile Dysfunction: diagnosed in 2014 Obesity Degenerative Joint Disease Past Surgical History Right hip replacement in 2013 with difficult intubation

Past Medical History Family History Cardiovascular Disease: Myocardial Infarctions (brother and mother), Type 2 Diabetes (brother) No neurological, autoimmune family history Social History Married with 3 adult children Small business owner 1-2 glasses of wine nightly, no smoking

Physical Exam Vitals: General: NAD HEENT: mmm Cardiac: RRR, no murmurs Lungs: CTAB Abdomen: obese, NT, ND Extremities: without atrophy Neurologic: CN 2-12 intact, but with mild dysarthria. No word finding difficulties. No tremor with rest, action, or posture. Rocks to stand. 5/5 upper and lower extremity strength Negative Romberg. Finger to nose, heel to shin with mild right>left dysmetria bilaterally. Gait: slightly wide base, decreased arm swing bilaterally, stooped posture Medications: sildenafil, plaquenil

Investigations Labs B 12, TSH, CPK all WNL

MRI 11/15 Investigations

Investigations JANUARY 2016: NEUROLOGY CONSULT Additional Clinical Information: Decreased Blink Frequency EMG: normal Referral to Movement Disorders Clinic

Investigations DaT- SPECT scan (Dopamine Transport Imaging with Single-Photon Emission Computed Tomography) Radioligands attach to the dopamine transporter (DaT), a protein on the presynaptic membrane which serves as a portal for dopamine update. Detects abnormal signal update in the striatum in patients with PD and other disease with nigrostriatal deficits

Investigations

DaT Scan- June 2016 Abnormal size, shape and activity both basal ganglia. Prominent decreased activity both putamen. Moderate decreased activity both caudate nuclei

Differential Diagnosis Parkinson s Disease Motor Neuron Disease Atypical Parkinson s Multiple System Atrophy Lewy Body Dementia

Clinical Update MAY 2017 Sudden leg weakness Unable to get out of bed Orthostatic, with standing SBP 70 Now choking with meals Started on fludrocortisone

Multiple System Atrophy Progressive fatal neurodegenerative disease characterized by Progressive autonomic failure Parkinsonian features Cerebellar and Pyramidal Features Major diagnostic challenge with relevance in: Cardiology GI ENT Urology Sleep Medicine

History 1969: combined three neurologic entities: Olivopontocerebellar atrophy Shy-Drager syndrome Striatonigral degeneration

Diagnosis Definite MSA Postmortem Diagnosis Alpha synuclein positive glial cytoplasmic inclusions Neurodegenerative changes in striatonigral or olivopontocerebellar region Probable Sporadic, progressive disease in adults after 30 yr characterized by autonomic failure, including urinary incontinence (with ED in men), or an orthostatic hypotension plus either Parkinsonian or cerebellar features

Epidemiology Rare orphan disease Incidence 0.6 0.7: 100,000 Prevalence: 3.4 4.9: 100,000 2 forms MSA- P: Parkinsonian features, more common in North America and Europe MSA- C: cerebellar features, more common in Japan Disease Onset: usually sixth decade with both sexes affected equally Survival: 6-10 years

Causes Unknown Sporadic Some families genetics Loss of function mutation COQ2 in some Japanese and sporadic cases Loss of copy number of SHC 2 in monozygotic twins and Japanese patients with sporadic MSA Mutations, duplications, and triplications of SNCA may cause Parkinson s disease with features similar to MSA

Neuropathological Features Variable degrees of olivopontocerebellar atrophy cerebellar syndrome striatonigral degeneration poorly levodopa responsive parkinsonism Degeneration of brain stem and medullary autonomic nuclei multidomain autonomic failure Oligodendroglialopathy Histology: Proteinaceous oligodendroglial cytoplasmic inclusions (Papp-Lantos bodies) Misfolded alpha-synuclein, normally found in neuronal axons and synapses

Clinical Presentation Prodromal premotor phase Sexual dysfunction Urinary urge incontinence Orthostatic Hypotension Inspiratory Stridor Rapid Eye Movement Sleep Behavior Disorder

REM Sleep Behavior Disorder (RBD) Abnormal behaviors during REM sleep Vocalizations and complex motor ranging from aggressive to pleasurable. Dream enactment behavior Polysomnography- loss of skeletal muscle atonia during REM sleep 50% with spontaneous RBD develop parkinsonism 1817 An Essay on Shaking Palsy : Case VI demonstrated a violent parasomnia 81-90% develop a neurodegenerative disorder Most reveal alpha synuclein abnormalities post mortem

Clinical Presentation Motor Features Multiple System Atrophy- Parkinsonism (MSA-P) Slowness of movements, rigidity, fall tendency Lack of pill rolling tremor Irregular postural and action tremor with superimposed jerks (50%) Degeneration of striatum poor response to levodopa though transient response can be seen in 40% of patients

Clinical Presentation Motor Features Multiple System Atrophy- Cerebellar Cerebellar ataxia Wide based gait, uncoordinated limb movements, action tremor, downbeat nystagmus Lack of spasticity Can see hyperreflexia in 30-50% of cases Abnormal posturing: bent spine and antecollis Dysphonia, dysarthria, dysphagia Recurrent falls

Clinical Presentation Nonmotor Features Autonomic dysfunction hallmark of disease Erectile Dysfunction Urinary Dysfunction Often misdiagnosed as BPH in men or perineal laxity in women Orthostatic Hypotension Syncope, dizziness, weakness, nausea, pain in neck and shoulder region

Clinical Presentation Nonmotor Features Respiratory disturbances Inspiratory stridor in 50% of patients especially in advanced disease This can occur with sleep apnea together Risk factor for sudden death Autonomic Failure Constipation, Thermoregulatory Problems

Clinical Presentation Nonmotor Features Dementia and hallucinations are not a part of the disease Frontal lobe dysfunction can occur- emotional incontinence, behavioral changes Depression, anxiety, and suicidal ideation are more common

Radiographic Signs MRI MSA-P: atrophy of putamen, middle cerebellar peduncle, pons or cerebellum putaminal rim sign- hyperintense signal of the dorsolateral border of putamen plus putaminal hypointensity in T 2 weighted sequences MSA- C Atrophy of putamen, middle cerebellar peduncle, or pons Hot cross bun sign (Cruciform hyperintensity in the pons) in T 2 weighted sequences Putaminal rim sign and hot cross bun signs are specific but not sensitive

Disease Progression Worsening of symptoms over 10 year period 50%: walking aids within 3 years 60%: wheelchair by 5 years 6-8 years: bedridden Causes of death: Pneumonia, Sepsis secondary to UTI, Sudden Death due to bilateral vocal cord paralysis or disruption of brainstem cardiorespiratory drive Poor prognostic indicators: older age, parkinsonian phenotype, and early development of severe autonomic failure

Disease Progression

Treatments Symptomatic therapy with low evidence Motor Features Slow increase in levodopa- 40% responsive at first

Treatments Nonmotor Features Neurogenic bladder: screen regularly for UTIs Urge incontinence: antimuscarinic agents, with caution Sildenafil for ED ; intracavernous injections of prostaglandins may be an alternative Orthostatic hypotension Fludrocortisone or midodrine Behavioral changes Inspiratory Stridor or Sleep Apnea CPAP or botox injection in vocal cord adductors Glycopyrrolate or botox of salivary glands for drooling, impaired swallowing

Acknowledgements Thank you to: Dr. William Medd Dr. Sarah Dodwell Dr. Erich Russell Dr. Stephen Hayes

References Fanciulli A, Wenning GK. Multiple-System Atrophy. N Engl J Med 2015; 372: 249-63. Howell, MJ, Schenck CH. Rapid Eye Movement Sleep Behavior Disorder and Neurodegenerative Disease. JAMA Neurology 2015; 72 (6); 707-12. Quinn, Niall. Multiple System Atrophy- the nature of the beast. Journal of Neurology, Neurosurgery, and Psychiatry. Special Supplement. 1989: 78-89. Bega, D, Gonzalez-Latapi, P, Zadikoff, C, et al. Is there a role for DAT-SPECT imaging in a Specialty Movement Disorders Practice? Neurodegener Dis 2015; 15: 81-86.